Discovery of Novel Bis-Evodiamine Derivatives with Potent Antitumor Activity.

Huixin Liang,Wei Wang,Fugui Zhu,Shuqiang Chen,Dan Liu,Chunquan Sheng
DOI: https://doi.org/10.1016/j.bmc.2022.116793
IF: 3.461
2022-01-01
Bioorganic & Medicinal Chemistry
Abstract:Inspired by antitumor natural product evodiamine, a series of novel bis-evodiamine derivatives were designed and synthesized, which showed potent antitumor activity. In particular, compound 13b effectively inhibited the proliferation and migration of HCT116 cells. Further mechanism studies revealed that compound 13b acted by inducing HCT116 cell apoptosis and arresting the cell cycle at the G2/M phase. Thus, compound 13b represents a promising lead compound for the discovery of novel antitumor agents.
What problem does this paper attempt to address?